enow.com Web Search

  1. Ad

    related to: xolair side effects after injection for macular degeneration

Search results

  1. Results from the WOW.Com Content Network
  2. Omalizumab - Wikipedia

    en.wikipedia.org/wiki/Omalizumab

    Omalizumab, sold under the brand name Xolair among others, is an injectable medication to treat severe persistent allergic forms of asthma, nasal polyps, urticaria (hives), [11] [12] and immunoglobulin E-mediated food allergy. [13]

  3. Macular degeneration - Wikipedia

    en.wikipedia.org/wiki/Macular_degeneration

    The incidence of age-related macular degeneration and its associated features increases with age and is low in people <55 years of age. [101] Smoking is the strongest modifiable risk factor. [102] As of 2008, age-related macular degeneration accounts for more than 54% of all vision loss in the white population in the US. [103]

  4. Intravitreal injection - Wikipedia

    en.wikipedia.org/wiki/Intravitreal_injection

    Intravitreal injection was first mentioned in a study in 1911, in which the injection of air was used to repair a detached retina. [6] [7] [8] There were also investigations evaluating intravitreal antibiotics injection using sulfanilamide and penicillin to treat endophthalmitis in the 1940s, yet due to the inconsistency of results and safety concerns, this form of drug delivery was only for ...

  5. FDA approves medication used to treat asthma for use in ... - AOL

    www.aol.com/news/fda-approves-medication-used...

    The US Food and Drug Administration on Friday approved a medication called Xolair to help lessen the severity of an accidental allergic reaction in people who are allergic to multiple foods.

  6. Newly approved drug protects against multiple food allergies ...

    www.aol.com/news/newly-approved-drug-protects...

    The injectable drug was approved in 2003 under the name Xolair for chronic hives and allergic asthma, but now there was evidence it could also protect against severe allergic reactions to food ...

  7. FDA Approves Biosimilars for Macular Degeneration Treatment - AOL

    www.aol.com/lifestyle/fda-approves-biosimilars...

    The FDA approved two interchangeable biosimilars to treat macular degeneration. The biosimilars work the same way as Eylea which prevents abnormal blood vessel growth in the eye and helps preserve ...

  8. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    geographic atrophy secondary to age-related macular degeneration Lanadelumab [41] Takhzyro: mab: human: kallikrein: Y: angioedema: Landogrozumab [12] mab: humanized: GDF-8: muscle wasting disorders Laprituximab emtansine [41] mab: chimeric: epidermal growth factor receptor (EGFR) Larcaviximab [28] mab: chimeric: ebolavirus glycoprotein: Ebola ...

  9. Injection site reaction - Wikipedia

    en.wikipedia.org/wiki/Injection_site_reaction

    Injection site reactions (ISRs) are reactions that occur at the site of injection of a drug. They may be mild or severe and may or may not require medical intervention. Some reactions may appear immediately after injection, and some may be delayed. [1] Such reactions can occur with subcutaneous, intramuscular, or intravenous administration.

  1. Ad

    related to: xolair side effects after injection for macular degeneration